Janus kinase inhibitors for rheumatoid arthritis
Author:
Publisher
Elsevier BV
Subject
Biochemistry,Analytical Chemistry
Reference44 articles.
1. The effectiveness of early treatment with “second-line” antirheumatic drugs. A randomized, controlled trial;van der Heide;Ann Intern Med,1996
2. Discontinuation of biologics in patients with rheumatoid arthritis;Tanaka;Clin Exp Rheumatol,2013
3. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges;Smolen;Nat Rev Rheumatol,2015
4. Tyrosine kinases as targets for the treatment of rheumatoid arthritis;D’Aura Swanson;Nat Rev Rheumatol,2009
5. Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment;Walker;Ann Rheum Dis,2006
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A decade of USFDA-approved small molecules as anti-inflammatory agents: Recent trends and Commentaries on the “industrial” perspective;European Journal of Medicinal Chemistry;2024-01
2. Selective JAK1 inhibition using upadacitinib for the management of inflammatory bowel diseases;Canadian IBD Today;2023-11-23
3. Uncovering hidden therapeutic indications through drug repurposing with graph neural networks and heterogeneous data;Artificial Intelligence in Medicine;2023-11
4. STATs signaling pathways in dendritic cells: As potential therapeutic targets?;International Reviews of Immunology;2023-10-27
5. Upadacitinib and Cardiovascular Adverse Events in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis;2023-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3